News

Arcinova Q2 Newsletter 2017

Our Q2 Newsletter, with important updates including the expansion of our capabilties, new starters and upcoming conferences. 

 

Read more...

Arcinova Invests in Uniqsis FlowSyn™ Continuous Flow Reactor

In order to facilitate API development, Arcinova have invested in a Uniqsis FlowSyn™ continuous flow reactor.

 

 

Read more...

Integrated Services: Covance and Arcinova strategic relationship

A strategic relationship has been formed between Arcinova and global CRDO Covance. The two companies are now providing integrated services to the global biotech and pharma industry.

 

Read more...

Enterprise Hub founding Chair to receive President’s Medal

Director at Arcinova, Ian Shott, is set to receive the President's Medal for his many contributions to the work of the academy over the years, which has ultimately resulted in the creation of the Enterprise Hub. 

Read more...

FW Capital: Arcinova set to grow with £750,000 investment

Alnwick-based independent pharmaceutical contract research and development business Arcinova is set to grow thanks to a £750,000 investment via a loan from the North East Growth Plus Fund managed by FW Capital.

Read more...

Arcinova Q1 Newsletter 2017

Our Q1 Newsletter, with important updates including the expansion of our capabilties, new starters and upcoming conferences. 

 

Read more...

Rural Funding Helps Arcinova Expand Capabilities

With the help of Arch Business, Arcinova have received funding from the Rural Growth Network Fund to support the installation of 20L API streams. 

 

Read more...

Arcinova Invests in State of the Art LC-MS Equipment

Arcinova have invested in the latest Waters Xevo® TQ-XS Triple Quadrupole Mass Spectrometry system.  

 

Read more...

French Tax Authority Grants Arcinova with R&D Organisation Status

An application to the French Tax Authority for 'R&D organisation' status has now been approved. 

 

 

Read more...